9-(2-O-Acetyl-5-O-toluyl-3-deoxy-3-fluoro-beta-D-ribofuranosyl)-6-chloro-9H-purine

9-(2-O-Acetyl-5-O-toluyl-3-deoxy-3-fluoro-beta-D-ribofuranosyl)-6-chloro-9H-purine Suppliers list
Company Name: Zhengzhou Granlen Sciences, ltd.  
Tel: 0371-85513397 +86-18610099868
Email: info@granlen.com
Company Name: NewCan Biotech Limited  
Tel: +86-571-86912261 19975279805
Email: sales@newcanbio.com
Company Name: NINGBOBENKANGJS PHARMTECHCO., LTD  
Tel: +8615990591583 15990591583
Email:
Company Name: Ningbo Benkang jishi Pharmaceutical Technology Co., Ltd.  
Tel: 15990591583
Email:
Company Name: TargetMol Chemicals Inc.  
Tel: 4008200310 15002144251
Email: marketing@tsbiochem.com

9-(2-O-Acetyl-5-O-toluyl-3-deoxy-3-fluoro-beta-D-ribofuranosyl)-6-chloro-9H-purine manufacturers

9-(2-O-Acetyl-5-O-toluyl-3-deoxy-3-fluoro-beta-D-ribofuranosyl)-6-chloro-9H-purine Basic information
Product Name:9-(2-O-Acetyl-5-O-toluyl-3-deoxy-3-fluoro-beta-D-ribofuranosyl)-6-chloro-9H-purine
Synonyms:9-(2-O-Acetyl-5-O-toluyl-3-deoxy-3-fluoro-beta-D-ribofuranosyl)-6-chloro-9H-purine;9-(2-O-Acetyl-5-O-(p-Toluoyl)-3-deoxy-3-fluoro-beta-D-ribofuranosyl)-6-chloro-9H-purine;9H-Purine, 9-[2-O-acetyl-3-deoxy-3-fluoro-5-O-(4-methylbenzoyl)-β-D-ribofuranosyl]-6-chloro-;5’-O-(p-Toluoyl)-2’-O-acetyl-3’-deoxy-3’-fluoro-6-chloroinosine;9-(2-O-Acetyl-5-O-(p-toluoyl)-3-deoxy-3-fluoro-β-D-ribofuranosyl)-6-chloro-9H-purine
CAS:1612192-06-9
MF:C20H18ClFN4O5
MW:448.84
EINECS:
Product Categories:
Mol File:1612192-06-9.mol
9-(2-O-Acetyl-5-O-toluyl-3-deoxy-3-fluoro-beta-D-ribofuranosyl)-6-chloro-9H-purine Structure
9-(2-O-Acetyl-5-O-toluyl-3-deoxy-3-fluoro-beta-D-ribofuranosyl)-6-chloro-9H-purine Chemical Properties
Boiling point 606.2±65.0 °C(Predicted)
density 1.54±0.1 g/cm3(Predicted)
pka0.76±0.10(Predicted)
Safety Information
MSDS Information
9-(2-O-Acetyl-5-O-toluyl-3-deoxy-3-fluoro-beta-D-ribofuranosyl)-6-chloro-9H-purine Usage And Synthesis
Uses5’-O-(p-Toluoyl)-2’-O-acetyl-3’-deoxy-3’-fluoro-6-chloroinosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
References[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005
9-(2-O-Acetyl-5-O-toluyl-3-deoxy-3-fluoro-beta-D-ribofuranosyl)-6-chloro-9H-purine Preparation Products And Raw materials
Tag:9-(2-O-Acetyl-5-O-toluyl-3-deoxy-3-fluoro-beta-D-ribofuranosyl)-6-chloro-9H-purine(1612192-06-9) Related Product Information
9-(2-O-Acetyl-5-O-toluyl-3-deoxy-3-fluoro-beta-D-ribofuranosyl)-2-amino-6-chloro-9H-purine 9-(2'-O-Acetyl-5'-O-benzoyl-3'-O-Methyl-beta-D-ribofuranosyl)-2,6-dichloropurine 9-(2'-O-Acetyl-5'-O-benzoyl-3'-O-Methyl-beta-D-ribofuranosyl)-6-chloropurine N6-Benzoyl-9-(5-O-benzoyl-2'-deoxy-beta-D-threo-pentofuranosyl)adenine 5-Chloro-2'-deoxyuridine Raltitrexed